MYO myomo.com: Forward P/S Multiple

Graphic logo of Myomo, Inc (MYO)

Myomo, Inc. (MYO) ensures reliability through strict control over the final assembly of exoskeletons while partially outsourcing electronics. This chart of the company's expected P/S clearly confirms market expectations, where the metric is maintained at 1.10. Business growth is based on Medicare reimbursement approvals and stable cash flow, as well as the recognition of robotic systems by insurance funds and the medical community.

myomo.com - MYO Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/14/2026)

Metric breakdowns and analytics for Myomo Inc (MYO)

- current price and projected stock value:
- company stock capitalization data:
Summary company analytics:Myomo (MYO)
Product sample of Myomo, Inc.

The forward P/S ratio determines the market value of an asset relative to expected annual revenue, allowing investors to assess the extent of overpayment for future cash flows. By analyzing the forward P/S of the company, one can compare sales growth rates with the capitalization of Myomo, Inc., whose unique reputation in the field of robotic prosthetics justifies a premium valuation due to the high value of restoring patient mobility.

Key competitors

Forward P/S Multiple BSX (Boston Scientific Corporation)|Edwards (EW) - Market Cap to Future Revenue Ratio|ResMed Corp - Forward P/S Multiple|PODD (Insulet Inc.) - Market Cap to Projected Revenue|ZBH: Forward P/S Multiple|COO - Market Cap to Expected Sales Ratio|ALGN (Align Technology) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Globus Medical Inc (GMED)|Forward P/S Multiple TMDX|Forward P/S Multiple Alphatec Corp (ATEC)|Price-to-Projected Revenue Ratio Artivion, Inc. AORT|enovis.com - Price-to-Projected Revenue Ratio|IART: Forward Price-to-Revenue Multiple|Forward Price to Sales ESTA (Establishment Labs Corp)|BBNX: Forward P/S Multiple|Market Cap to Future Revenue Ratio IRADIMED Inc. (IRMD)|Price-to-Projected Revenue Ratio Embecta Corp.|TNDM - Projected Price to Revenue|Forward Price-to-Revenue Multiple AXGN (Axogen)|Forward P/S Multiple SI-BONE Inc (SIBN)|Forward P/S Multiple OFIX (Orthofix International)|Market Cap to Expected Sales Ratio Bioventus Global (BVS)|KIDS - Price-to-Projected Revenue Ratio|Future Price to Revenue TMCI|Strata Critical Medical (SRTA) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Carlsmed, Inc.|RXST (RxSight Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio ClearPoint CLPT|Price-to-Projected Revenue Ratio Stereotaxis, Inc. (STXS)|neurostar.com - Market Cap to Projected Revenue|Sight Sciences - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio OBIO (Orchestra BioMed Inc.)|ANIK - Price-to-Projected Revenue Ratio|InspireMD Inc. (NSPR) - Forward Price-to-Revenue Multiple|ZJYL (zhjmedical.com) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio Vivani Medical (VANI)|Price-to-Projected Revenue Ratio Xtant Medical Holdings, Inc.|Market Cap to Future Revenue Ratio NeuroOne NMTC|Price-to-Projected Revenue Ratio Modular Medical (MODD)|Forward Price-to-Revenue Multiple Envoy Medical Inc COCH|Price-to-Projected Revenue Ratio Vivos Therapeutics VVOS|envveno.com (NVNO) - Market Cap to Future Revenue Ratio|SINT: Forward Price-to-Revenue Multiple|Forward Price to Sales TNON (Tenon Medical Inc.)|LFWD: Forward P/S Multiple|AMIX - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio INVO Fertility Inc|Market Cap to Projected Revenue BBLG (bonebiologics.com)|Forward P/S Multiple AXNX|Forward Price-to-Revenue Multiple BIOLASE Inc. BIOL|Dynatronics - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Paragon 28 Inc. (FNA)|INVO - Price-to-Projected Revenue Ratio